The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo.
about
IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis.Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas.Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy.
P2860
The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The oncometabolite D-2-hydroxy ...... ntiation in vitro and in vivo.
@ast
The oncometabolite D-2-hydroxy ...... ntiation in vitro and in vivo.
@en
type
label
The oncometabolite D-2-hydroxy ...... ntiation in vitro and in vivo.
@ast
The oncometabolite D-2-hydroxy ...... ntiation in vitro and in vivo.
@en
prefLabel
The oncometabolite D-2-hydroxy ...... ntiation in vitro and in vivo.
@ast
The oncometabolite D-2-hydroxy ...... ntiation in vitro and in vivo.
@en
P2093
P2860
P356
P1433
P1476
The oncometabolite D-2-hydroxy ...... ntiation in vitro and in vivo.
@en
P2093
Anne-Marie Cleton-Jansen
Helene Roelofs
Johnny Suijker
Judith V M G Bovée
P2860
P304
14832-14842
P356
10.18632/ONCOTARGET.4024
P407
P577
2015-06-01T00:00:00Z